Black and white portrait representing chronic migraine concern at CAMIBlack and white portrait representing chronic migraine concern at CAMI

Chronic Migraine: How Botox Became a Proven Prevention Treatment

Botox is FDA-approved for chronic migraine prevention in adults with 15 or more headache days per month. Precise injections every 12 weeks reduce frequency significantly.

get started
Wellness & Hormones

Botox for migraine isn't an off-label experiment. It's been FDA-approved for over a decade.

What It Is

Chronic migraine is defined clinically as 15 or more headache days per month, with at least 8 of those meeting criteria for migraine — typically moderate to severe head pain lasting 4–72 hours, often accompanied by nausea, photosensitivity, and phonosensitivity.

It is distinct from episodic migraine (fewer than 15 headache days per month) and is classified as a neurological condition, not simply a severe headache. The frequency and duration of chronic migraine significantly impair quality of life, work productivity, and daily function.

Why Patients Seek Treatment

Patients come in after years of trying preventive medications that either don't work or produce side effects they can't tolerate. The appeal of Botox for migraine is that it works through a different mechanism than oral medications — and for many patients, it produces a meaningful reduction in headache days where nothing else has.

UNDERSTANDING THE SCIENCE

Chronic migraine is a neurological condition. Botox addresses it by interrupting the pain signaling pathway.

What Causes It
Common Signs
Why It Changes Over Time
How It's Commonly Addressed
01

What Causes It

Migraine is driven by complex neurological and vascular mechanisms that are not fully understood. The current leading model involves activation and sensitization of the trigeminal nerve system — a network of pain-sensing nerves in the head and face — along with changes in brain chemistry, particularly involving serotonin and calcitonin gene-related peptide (CGRP).

Chronic migraine often develops from episodic migraine through a process called chronification, which is associated with overuse of acute pain medications, sleep disruption, hormonal fluctuations, and psychological stress. Genetics play a significant role.

02

Common Signs

Patients with chronic migraine typically experience:

  • 15 or more headache days per month, most of which are moderate to severe
  • Throbbing or pulsating head pain, typically on one side
  • Nausea, vomiting, or both
  • Significant sensitivity to light and sound during attacks
  • Prodrome symptoms in the hours before a headache — mood changes, neck stiffness, light sensitivity, food cravings
  • Significant functional impairment during attacks and on high-frequency headache days
03

Why It Changes Over Time

For many patients, migraine begins in adolescence or early adulthood as episodic attacks. Over time — particularly in the absence of effective preventive treatment — the frequency can increase, transitioning to chronic migraine.

Hormonal changes in women, particularly around perimenopause, frequently affect migraine patterns. Some patients find that frequency increases significantly during this period; others experience improvement post-menopause.

Without intervention, chronic migraine tends to persist or worsen. With consistent preventive treatment — including Botox — many patients return to episodic patterns or experience significantly reduced frequency.

04

How It's Commonly Addressed

Chronic migraine management typically involves a combination of acute treatments (used at the time of an attack) and preventive treatments (used consistently to reduce attack frequency).

  • Botox (onabotulinumtoxinA): FDA-approved since 2010 for the prevention of chronic migraine in adults. Administered as a series of injections across 31 specific sites on the head and neck every 12 weeks. Clinical trials show a reduction of approximately 8–9 headache days per month in qualifying patients.
  • Oral preventive medications: Beta-blockers, tricyclic antidepressants, anticonvulsants, and CGRP antagonists are first-line oral options. Many patients try multiple medications before finding one that is effective and tolerable.
  • Lifestyle management: Consistent sleep schedule, hydration, stress management, and trigger identification all contribute to frequency reduction.
  • Acute rescue medications: Triptans, NSAIDS, and anti-nausea medications manage individual attacks but do not reduce frequency when used as standalone treatment.

We Follow The FDA Protocol. And We Look At The Full Picture.

At CAMI, Botox for chronic migraine is offered to patients who meet the clinical criteria — 15 or more headache days per month — and who are under the medical oversight of Dr. Reid. We follow the FDA-approved protocol: 31 injection sites across the forehead, temples, back of the head, neck, and upper shoulders, administered every 12 weeks.

We also work to understand the full picture. A patient with chronic migraine may also have hormonal factors, sleep disturbances, or metabolic contributors that CAMI is positioned to address. The most complete outcomes come from addressing migraine as part of a broader wellness conversation, not as an isolated injectable appointment.

get started

Treatments for
This Concern

FAQ

How does Botox treat chronic migraines?
How long before Botox reduces migraine frequency?
What does general wellness support involve at CAMI?
Why does hormonal change cause fatigue and low energy?

Explore Related
concerns